These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 495247

  • 1. Mazindol: its efficacy and mode of action in generating weight loss.
    Johnson WG, Hughes JR.
    Addict Behav; 1979; 4(3):237-44. PubMed ID: 495247
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of obesity with a non-amphetamine anorexigenic agent (author's transl)].
    Riesco J, Troncoso G, Costamaillere L, Rodríguez J.
    Rev Med Chil; 1977 Jun; 105(6):375-9. PubMed ID: 331428
    [No Abstract] [Full Text] [Related]

  • 4. AN 448 Sandoz (Mazindol) in the treatment of obesity.
    Wallace AG.
    Med J Aust; 1976 Mar 13; 1(11):343-5. PubMed ID: 775265
    [Abstract] [Full Text] [Related]

  • 5. [Clinical use of mazindol in the treatment of essential obesity].
    Guazzelli R, Piazzini M, Conti C, Papi L, Strazzulla G, Matassi L.
    Clin Ter; 1987 Mar 15; 120(5):385-91. PubMed ID: 2953538
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Double-blind clinical evaluation of mazindol (42-548) in obese diabetics.
    Bandisode MS, Boshell BR.
    Curr Ther Res Clin Exp; 1975 Dec 15; 18(6):816-24. PubMed ID: 813947
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A multi-centre trial of mazindol ('Teronac') in general practice in Ireland.
    Evans ER, Wallace MG.
    Curr Med Res Opin; 1975 Dec 15; 3(3):132-7. PubMed ID: 1149481
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mazindol (Teronac)- another anorectic drug.
    Drug Ther Bull; 1974 Dec 20; 12(26):101-2. PubMed ID: 4459058
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Mazindol in the treatment of simple obesity].
    Siciński A, Stasiakowa L.
    Pol Arch Med Wewn; 1976 Jun 20; 55(6):581-7. PubMed ID: 781631
    [No Abstract] [Full Text] [Related]

  • 16. Double-blind trial of mazindol in overweight patients.
    Heber KR.
    Med J Aust; 1975 Oct 04; 2(14):566-7. PubMed ID: 1105106
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of the anorectic effect of mazindol and placebo in obesity].
    Tatoń J, Czech A, Koliński P, Podwysocka G.
    Pol Tyg Lek; 1979 Dec 10; 34(50):1967-70. PubMed ID: 395517
    [No Abstract] [Full Text] [Related]

  • 18. [Mazindol (AN-448): a new non-amphetamine anorectic in the treatment of exogenous obesity].
    Delitala G, Alagna S, Masala A.
    Clin Ter; 1977 Jun 30; 81(6):547-54. PubMed ID: 884939
    [No Abstract] [Full Text] [Related]

  • 19. Mazindol in the control of micturition.
    Woodhouse CR, Tiptaft RC.
    Br J Urol; 1983 Dec 30; 55(6):636-8. PubMed ID: 6360295
    [Abstract] [Full Text] [Related]

  • 20. Double blind clinical trial of mazindol on weight loss blood glucose, plasma insulin and serum lipids in overweight diabetic patients.
    Slama G, Selmi A, Hautecouverture M, Tchobroutsky G.
    Diabete Metab; 1978 Sep 30; 4(3):193-9. PubMed ID: 361463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.